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CC BY-NC-ND license (http://creativeAbstract The aim of this study was to evaluate outcomes of robotic partial nephrectomy (RAPN)
procedures. At two centers, 42 patients underwent RAPN. Radius, Exo/Endophytic, Nearness,
Anterior/Posterior, Location (R.E.N.A.L.) nephrometry and PADUA scores of patients were calcu-
lated by computed tomography (CT) or magnetic resonance imaging (MRI). Intra- and periopera-
tive (0e30 days) complications were evaluated using modified Clavien classification. A four-arm
da Vinci-S robotic surgical system was used and outcomes were evaluated retrospectively. Mean
age of the patients was 52.3 6.5 years. Mean tumor size was 3.1 1.0 (1.4e6.6) cm. R.E.N.A.L.
nephrometry and PADUA scoreswere 6.0 1.5 and 7.5 0.9, respectively. Mean surgical timewas
127.7 18.7 minutes and estimated blood loss was 100  18.1 cc. Mean warm ischemia time was
16.0  8.9 (0e30) minutes. Intraoperative complications did not develop in any patient. Median
hospital stay was 3.0 (2e6) days. Except for 17 patients, hilar clamping was performed in 25 pa-
tients. Histopathology results included 34 renal cell carcinoma (22 clear cell, 7 chromophobe cell,
4 papillary cell, and 1 clear papillary cell). Oncocytoma (nZ 4), adenoma (nZ 1), fibroadipose
tissue (nZ 1), papillary epithelial hyperplasia (nZ 1), and chronic pyelonephritis (nZ 1) were
present. Surgical margins were negative in all patients. During a median follow-up period of
15.5  10.9 (3e46) months, neither local recurrence nor distant metastasis was detected. In
conclusion, RAPN is a safe,minimally invasive surgical approach, with excellent surgical and onco-
logical outcomes in T1 kidney tumors. Zero ischemia off-clamp RAPN is also safe in selected
masses with the advantage of avoiding complete renal ischemia.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).eclare no conflicts of interest.
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Robotic partial nephrectomy for stage T1 tumors 17IntroductionAlthough the only curative treatment of renal cell cancers
>4 cm is radical nephrectomy (RN), partial nephrectomy
(PN) is the gold standard treatment option for tumors
<4 cm [1]. Similar oncological results of PN and RN have
been previously reported [2]. Robot-assisted laparoscopic
transperitoneal partial nephrectomy (RAPN) offers advan-
tages including the three-dimensional and magnified view
of the surgical field and excellent control of the robotic
instruments [3]. The utilization of the robot in this field has
facilitated the PN procedure, especially during the renal
parenchymal dissection, and in the phases of suturing and
warm ischemia after excision of the tumor [4]. RAPN is
being increasingly preferred in medical centers with robotic
technology. In the current study, we evaluate the results
obtained at two centers of our initial consecutive RAPN
patients.
Methods
This study was approved by the Institutional Review Board
of Yildirim Beyazit University, School of Medicine, Ankara,
Turkey, and the consent of each patient for the use of their
information was obtained in writing. Between 2009 and
2015, a total of 42 patients underwent RAPN trans-
peritoneally, using the four-arm da Vinci-S robotic surgical
system (Intuitive Surgical Inc., Sunnyvale, CA, USA). In
order to determine the location and size of the mass,
abdominal computed tomography (CT) or magnetic reso-
nance imaging (MRI) was performed. The R.E.N.A.L.
nephrometry and PADUA scores of all 42 patients were
calculated from the examination of the CT and MRI scans
[5,6]. Intra- and perioperative (1e30 days) complications
were evaluated with regard to the modified Clavien clas-
sification system [7]. In addition, the patients’ age, sex,
body mass index (BMI), American Society of Anesthesiolo-
gists (ASA) score, radiologic tumor size, pathological tumor
size, nuclear grade of the tumor according to Fuhrman
system [8], and histological subtypes of the tumors in
accordance with the classification of the World Health Or-
ganization [9] were determined and the data were
recorded.
Patient preparation and positioning
In order to minimalize the risk of bleeding, antiaggregant
and anticoagulant treatment was discontinued in the pa-
tients at least 1 week prior to surgery. During the surgical
preparation phase, two units of erythrocyte suspension
were prepared for a possible blood transfusion. Antibiotic
prophylaxis was administered to all patients during anes-
thesia induction. Before the administration of the anes-
thesia, high-thigh antiembolism stockings were applied to
both legs to prevent deep vein thrombosis and emboliza-
tion. After intratracheal general anesthesia, a urethral
Foley catheter was inserted, and the patient was then
placed in the 60 flank position with the surgical bed flexed,
which allowed a clear view of the surgical field. The sur-
gical field was cleaned with povidone iodine and all pa-
tients received 500 mg ciprofloxacin antibiotic prophylaxisintravenously. In regard to the surgeon’s preference, an
intraperitoneal incision was performed by inserting a Veress
needle or with the open Hasson method, approximately
1 cm lateral to the umbilicus to begin surgical access.
Pneumoperitoneum at 15 mmHg was maintained with CO2
insufflation by placement of a 12-mm robotic camera
trocar. Then, an 8-mm port was placed approximately 4 cm
craniomedial to the spina iliaca anterior superior (SIAS) for
the first robotic arm, and an 8-mm robotic port was placed
at the arcus costarum at the midclavicular line under direct
vision for the second robotic arm. A 10-mm assistant port
was placed 2 cm medial to the line connecting the robotic
port and the camera port. Finally, at the surgeon’s discre-
tion if a third robotic arm was to be used, an 8-mm robotic
port was placed approximately 2 cm below the SIAS under
direct vision. The port placements were similarly per-
formed for the right and left kidneys. In some cases, for
right renal masses, a 5 mm additional port was placed
below the xiphoid process for the purpose of liver retrac-
tion. For the next step the robotic unit was docked at a 15
angle from the back of the patient and the operation was
began by connecting the robotic arms and introducing the
robotic instruments through the ports.
Surgical technique
During surgery, the standard partial nephrectomy procedure
was followed, including colon mobilization, hilar dissection,
tumor visualization, in on-clamp approaches clamping the
renal artery with a laparoscopic bulldog clamp, excision of
the tumor, renorrhaphy, and the removal of the clamp. Zero-
ischemia PN is preferred in peripherally located, exophytic,
small-sized mass lesions. The tumor was macroscopically
dissected with the robotic scissors until the normal paren-
chyma margin was visualized and the tumor was extracted
with the adipose tissue overlying it and placed in an endo-
bag. Bleeding sites on the tumor bed surface were cauter-
ized using monopolar and bipolar energy. Renal parenchymal
repair was accomplished using a4-0 V-Loc 90, 1200 30 cm 1/2
17 mm (Covidien, New Haven, CT, USA) suture for internal
renorrhaphy. Afterward, if required, an absorbable fibrin
sealant patch (TachoSil; Takeda Pharmaceutical Company,
Osaka, Japan) was applied to the tumor surface for
adequate hemostasis and an external renorrhaphy was per-
formed with a 3-0 V-Loc 180, 1800 45 cm, 1/2 26 mm (Covi-
dien) suture. Absorbable clips (Lapra-Ty (Ethicon Endo-
surgery, Inc., Cincinnati, OH, USA)) were placed reciprocally
across the sutures outside the renal capsule. Intra-
abdominal pressure was decreased to 5 mmHg at the end
of the procedure in order to check if adequate hemostasis
had been achieved. A drain was inserted through the trocar
site. After the robotic unit was undocked, the specimen in
the endobag was extracted from the abdominal cavity by
enlarging the insertion site of the camera port.
Postoperative follow-up
Patients were given intravenous fluids, analgesics, and an-
tibiotics postoperatively. Urethral catheters and drains
were removed and the patients were discharged from the
hospital. Routine biochemistry and hemogram tests were
Table 2 Perioperative and postoperative outcomes of 42
patients.
Surgical time (min) 127.7  18.7
Warm ischemia time (min) 16 (0e30)
Blood loss (mL) 100 (10e700)
Hospitalization time (d) 3 (2e6)
Follow up (mo) 15.5 (3e46)
Intraoperative complication 0
18 K. Ener et al.carried out immediately after surgery and on the 1st day
after surgery. A follow-up abdominal CT was carried out on
all patients in the postoperative third month, after which
patients were followed up with annual abdominal CT and
chest radiography.
Results
A total of 42 patients were included in the study with a
mean age of 52.3  6.5 (range 37e74) years. Of the 42
patients, 37 were male and five were female. The mean BMI
was 28.4  4.1 kg/m2 and R.E.N.A.L. nephrometry and
PADUA scores were 6.0  1.5 and 7.5  0.9, respectively.
The mean duration of surgery was 127.7  18.7 minutes,
and warm ischemia time was 16.0  8.9 minutes. The mean
intraoperative blood loss was 100.0  18.1 mL. There were
no intraoperative complications in any of the 42 patients. In
the perioperative period (1e30 days), only two patients
required blood transfusions (Clavien Grade 1 due to the
necessity of blood transfusion and radiological examina-
tion), and no complications were seen in the remaining 40
patients (Clavien Grade 0). The median hospital stay was
3.0 (2e6) days. After being discharged none of our patients
had to be readmitted for any reason. The mean radiological
and median pathological tumor sizes were 3.17  1.0
(1.4e6.6) cm and 2.7 (1e6.2) cm, respectively.
Histopathologic evaluation revealed that of 42 patients,
34 had renal cell carcinoma, four had oncocytoma, one had
adenoma, one had chronic pyelonephritis, one patient had
fibroadipose tissue, and one patient had papillary epithelial
hyperplasia. The renal cell carcinoma cases were of a clear
cell type in 22, whereas seven had chromophobe cells, four
had papillary cells, and one had clear papillary cells. The
Fuhrman grades were assessed as Grade 1 in six cases,
Grade II in 21 cases, and Grade III in seven cases. The sur-
gical margins were negative in all patients. Tumor charac-
teristics and operational outcomes are summarized in
Tables 1 and 2. During the median follow-up period of
15.5  10.9 (3e46) months, neither local recurrence nor
distant metastasis was detected in any of the patients.
Discussion
Radical nephrectomy is accepted as the gold standard in
the treatment of renal tumors. However, recent studies
have featured RAPN as a surgical method with similar
oncological efficiency and applicable for small renal massesTable 1 Tumor characteristics.
Radiological tumor size (cm) 3.17  1 (1.4e6.6)
Pathological tumor size (cm) 2.7 (1e6.2)
PADUA 7.5 (6e11)
R.E.N.A.L. nephrometry 6.0 (4e9)
Histopathological results
Renal cell cancer 34
Oncocytoma 4
Other (papillary hyperplasia,
pyelonephritis, adenoma, cyst)
4[10]. Since its introduction in 2004 [11], RAPN has been
presented as an alternative to open or laparoscopic PN as a
minimally invasive method. Robotic surgery has the ad-
vantages of removing tremor, providing surgeons with
enhanced capabilities including a three-dimensional,
magnified view, and fulfills the requirements of effective
laparoscopic surgery. In the literature, the number of
studies including RAPN series has increased in recent years
[12e18]. In the early studies, the results of initial experi-
ences were reported; however, now the results of quite
extensive series comparing robotic procedure with laparo-
scopic PN and open surgery are being published. The results
of various selected RAPN series are summarized in Table 3.
After the first publication in which the results of 13 patients
were evaluated, there are reports on multicenters in which
a series of 1035 patients are analyzed and thus the results
are considered to be more credible. The findings obtained
in this 10-year period show that RAPN is a feasible method
with a short ischemia time and good oncological outcomes.
In a multicenter study comparing open and robotic PN
procedures [18], no difference was observed in terms of
tumor nephrometry, renal function, ischemia time, positive
surgical margin, intra- and postoperative complications, in
an open PN group consisting of 198 patients, and robotic PN
group consisting of 105 patients. Nonetheless, less bleeding
and surgical complications, and shorter hospital stay have
been reported for the robotic PN group. In this study, the
duration of surgery for small renal masses was detected as
being longer for the patients in the robotic group. However,
studies reporting less bleeding, warm ischemia, and dura-
tion of surgery are dominant in the literature [12e22].
The spread of laparoscopic PN has been limited due to
the difficult technique and surgeons’ long learning curve. In
various publications, RAPN has been emphasized having a
shorter learning curve than the laparoscopic method [23].
At one center, where RAPN was performed on 62 patients, it
was reported that console time and warn ischemia time
were meaningfully decreased. In this study, after the first
30 procedures, it was shown that the console time dropped
to under 100 minutes and warm ischemia to under 20 mi-
nutes. Considering the patient number in our study, warm
ischemia time can be said to be at the targeted level for our
department and the robotic urology team. However, ac-
cording to the same study, it is clear that we need to
improve our practice in order to reach the optimal duration
for this surgical procedure. Nevertheless, when the litera-
ture is further reviewed, our results seem to be consistent
with the literature in terms of surgical time, despite the
fact that we had fewer cases. In another study, 20 patients
with laparoscopic PN and 11 patients with robotic PN were
Table 3 The results of selected robotic partial nephrectomy series in the literature.
Study Year No. of
patients
ST
(min)
EBL
(mL)
Warm ischemia
time (min)
Tumor
size
Intra-operative
complication (n)
Gettman et al [11] 2004 13 215 170 22 (clamp)
33 (cold)
3.5 0
Wang et al [20] 2009 40 140 136 19 2.5 2
Benway et al [21] 2009 12 189 155 19.7 2.9 2
Gill et al [26] 2013 886 183.6 100 18.8 3 23
Faria et al [24] 2014 137 192.5 125 20 2.7 15
Minervini et al [18] 2014 105 168 125 18.2 2.8 2.9
EBL Z estimated blood loss; ST Z surgical time.
Robotic partial nephrectomy for stage T1 tumors 19compared [22]. Although the tumor size was detected as
equal in both groups, the warm ischemia time was reported
as shorter in the robotic PN group. Ultimately, the authors
emphasized that robotic and laparoscopic methods are
credible and applicable in the treatment of T1 renal tumors
and the robotic method provides the advantage of tumor
excision under three-dimensional view and easy suturation.
In a retrospective study comparing 146 laparoscopic PN
patients and 137 robotic PN patients, ischemia time was
determined to be shorter in the robotic group [24]. It has
been stated that tumor excision time was not different
between the groups; however, the robotic surgery provided
an advantage in the application of the internal and external
renorrhaphy sutures.
During a RAPN procedure, the renal artery is clamped
before the excision of the renal mass; this is undertaken to
decrease hemorrhage and provide a clear surgical area for
dissection. However, arterial clamping temporarily cuts off
the blood flow to the entire kidney, which may diminish
renal function and become particularly problematic in pa-
tients with potential chronic renal diseases. For the pa-
tients with peripherally located, exophytic renal masses
that are <3 cm in size, zero ischemic or off-clamp RAPN
may be considered a safe option. Undoubtedly, the zero
ischemia RAPN technique may have a risk of hemorrhage; to
avoid this risk, a laparoscopic bulldog clamp must be
introduced into the abdominal cavity in order to apply it to
the renal artery when required. The effect of warm
ischemia on long-term renal function still remains unclear.
However, it is believed that decreasing the time for
ischemia can help to preserve long-term renal function.
Previously, a few zero ischemia techniques to minimize
entire renal ischemia were described [25,26], but there is
lack of data from larger series.
There are an increasing number of papers on the topic of
zero ischemic PN in the literature [25e30]. The results of
various zero ischemia robotic and laparoscopic PN studies
are summarized in Table 4. In a recent, retrospective,
multi-institutional study, the perioperative and functional
outcomes of RAPN, with (n Z 283) and without (n Z 49)
hilar clamping, were evaluated [28]. The off-clamp group
had a smaller tumor size, a significantly shorter surgical
time, greater estimated blood loss, and a smaller decrease
in estimated glomerular filtration rates (eGFR). The authors
concluded that zero ischemia RAPN is a safe and feasible
minimally invasive surgical option in selected patients with
small renal masses. Adequate surgical experience reducesthe risk of progression to renal insufficiency and enables
better preservation of kidney function. In a study consisting
of 289 laparoscopic PN cases, the perioperative outcomes
of off-clamp (nZ 150) and complete hilar control (nZ 139)
were evaluated [27]. The renal masses in the zero-ischemia
group were significantly smaller than those in the on-clamp
group. As a result, eGFR was preserved better in the zero-
ischemia group. The authors concluded that laparoscopic
PN without hilar clamping is associated with less renal
injury in terms of postoperative GFR, without any differ-
ences in the transfusion rate or positive surgical margin.
To identify anatomic characteristics of renal tumors in
CT and MRI and ensure a more objective and standard
evaluation of the masses prior to surgery, R.E.N.A.L.
nephrometry and the PADUA scoring systems have been
developed. Therefore, these scoring systems aid in pre-
dicting the oncological success of the applied surgical
method, and perioperative and postoperative complica-
tions of PN. Regarding R.E.N.A.L. nephrometry, the
complexity of the tumor is classified as low (4e6) or
medium-high (7e12). In the PADUA classification, renal
tumors were given scores from 6 to 14 according to their
anatomical localization. It has been shown that tumors with
a score of 8e9 carry 14 times the complication risk than
tumors with a score of 6e7, and tumors with a score of over
10 carry 30 times the complication risk than those with a
score of 6e7. In our study, R.E.N.A.L. nephrometry PADUA
scores were found to be low. Parallel to the low scores in
our series, intraoperative complications did not develop in
any patient; however, perioperative complications devel-
oped in only two patients and were managed with medical
therapy. In a study on RAPN in 886 patients [31], 115 pa-
tients developed postoperative complications, of which 77%
of the complications were Clavien IeII and were managed
conservatively. The authors suggested that these compli-
cation levels were acceptable, and comparable with other
surgical methods. It has been stated that the most
commonly encountered complication was hemorrhage and
the most important predictor in terms of complication
development was the nephrometry scoring system.
In the medical centers in the United States of America,
47% of the partial nephrectomies carried out in 2011 were
undertaken with robotic surgery [32]. The number of ro-
botic operations is estimated to increase in the world
because the use of robotic technology is rapidly expanding
and there are ever-increasing numbers of centers that have
this state-of- the-art equipment.
Table 4 The results of selected zero ischemia robotic and laparoscopic partial nephrectomy series in the literature.
Study No. of
patients
ST
(min)
EBL
(mL)
Tumor
size (cm)
Method Complication
Kaczmarek et al [28] 66 155 210 2.5 R No Clavien 3e5 complication
George et al [27] 150 137 338 2.7 L Less complication rates in the zero-ischemia group
Novak et al [25] 28 183 274 2.1 R 4.5%
Papalia et al [29] 78
43
57.8
58.3
168
205
4
>4
L,R 6.4%
18.6%
Gill et al [26] 57 264 206 3.2 L,R Clavien Grades 1e2 in 19.3% (Clavien Grades 3e5)
in 3.5%
Abreu et al [30] 21 222 150 4.1 R Clavien Grades 1e2 in 2 patients
On-clampa
Zero-ischemia
25
17
127.7 100 3 R No Clavien 2e5 complication
EBL Z estimated blood loss; L Z laparoscopic; R Z robotic; ST Z surgical time.
a Current study.
20 K. Ener et al.However, although there are undeniable advantages with
this technology, the disadvantage is the higher cost of ro-
botic surgical procedures. In addition, considering short
hospital stay and recovery, it can be expected that in the
future the cost of robotic procedures will decrease. In the
current study, we report the outcomes of our initial experi-
ence of RAPN. However, more samples with longer follow-up
are needed tomake a proper decision on the results. Another
limitation of this study is performing the procedure at two
centers by five surgeons. Although the console surgeons are
widely experienced in robotic surgery, the high number of
surgeons makes it difficult to standardize the results.
Our experience supports the idea that RAPN is a safe and
feasible minimally invasive surgical method with excellent
surgical and short-term oncological outcomes in the treat-
ment of small renalmasses. Zero-ischemia RAPN is also safe in
relation to the surgical management of selected kidney tu-
morswith the advantage of avoiding complete renal ischemia.References
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